Endovascular treatment strategies for supra-aortic arterial occlusive disease

P Peeters1, J Verbist, K Deloose

  • 1Department of Cardiovascular and Thoracic Surgery Imelda Hospital, Bonheiden, Belgium. patrick.peeters@imelda.be

Insights

Percutaneous therapy, including angioplasty and stenting, is now the preferred treatment for supra-aortic arterial occlusive disease due to its low morbidity. Advanced endovascular skills are crucial for success, with surgical options remaining essential for complex cases.

Area of Science:

  • Vascular Surgery
  • Interventional Cardiology
  • Endovascular Therapy

Background:

  • Supra-aortic arterial occlusive disease presents focal stenoses or occlusions.
  • High blood pressure in this vascular region poses challenges.
  • Percutaneous therapies offer low morbidity rates compared to surgery.

Purpose of the Study:

  • To highlight the shift towards percutaneous therapy for supra-aortic arterial occlusive disease.
  • To emphasize the technical success and durability of angioplasty and stenting.
  • To underscore the necessity of advanced endovascular skills and knowledge of surgical alternatives.

Main Methods:

  • Review of percutaneous angioplasty (PTA) and stenting outcomes.
  • Analysis of factors influencing PTA and stenting complexity.
  • Evaluation of the role of surgical reconstruction and bypass in endovascular failure or contraindications.

Main Results:

  • Percutaneous therapy has largely replaced surgical revascularization as the initial treatment.
  • Excellent initial technical success and durability are observed with PTA and stenting.
  • PTA and stenting can be complex, demanding advanced endovascular expertise.

Conclusions:

  • Percutaneous angioplasty and stenting are the primary treatment for supra-aortic arterial occlusive disease.
  • While effective, these endovascular techniques require specialized skills.
  • Surgical reconstruction and bypass remain vital for managing treatment failures or contraindications.

Related Concept Videos

Aneurysm III: Interprofessional Care01:26

Aneurysm III: Interprofessional Care

Aneurysm management involves either conservative medical therapy or surgical intervention, depending on the size and symptoms of the aneurysm. Conservative management is generally reserved for smaller, asymptomatic aneurysms, while larger or symptomatic aneurysms often necessitate surgical repair.Conservative Medical TherapyFor small, asymptomatic aneurysms, particularly abdominal aortic aneurysms (AAA) less than 5.5 centimeters in diameter, conservative medical therapy is recommended. This...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Aneurysm IV: Nursing Management01:22

Aneurysm IV: Nursing Management

Vigilant monitoring for aneurysm rupture is essential for patients undergoing aortic surgery.Preoperative Nursing ManagementContinuously monitor the patient for manifestations of aneurysm rupture, such as pallor, weakness, tachycardia, hypotension, abdominal, back, groin, or periumbilical pain, changes in consciousness, and a pulsating abdominal mass. Regularly assess the patient's peripheral pulses.Instruct the patient to consume a clear liquid diet the day before surgery and administer...